Medical Scientist _Oncology at Gilead Sciences

Tokyo, Japan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Strong industry experience is required
Establish and maintain effective working relationships with Oncology Key Opinion Leaders (KOLs) and other key external stakeholders
Be recognized as an innovative and value partner in improving quality of care for oncology patients
Maintain clinical, scientific, and technical expertise in Oncology
Ensure all interactions and activities in Japan adhere to corporate compliance guidance/rules and industry code of conduct

Responsibilities

Provide scientific/medical guidance to stakeholders in collaboration and close communication with the Japan Medical Affairs members, global/Asia Medical Affairs, and other key functions
Manage regular communication with Oncology KOLs and clinical trial investigators
Develop and execute medical activities, such as medical education, data generation, and patient-centric activities, in alignment with the Plan Of Action (POA) and strategic priorities
Attend major conferences and coordinate medical affairs activities (e.g., advisory board meetings) and present to external audiences
Manage projects to completion, anticipating obstacles and difficulties, and resolving them collaboratively
Provide answers to questions and additional data in response to issues that arise relative to commercial, scientific, or data needs

Skills

Oncology

KOL Management

Medical Affairs

Scientific Communication

Clinical Expertise

Compliance

Project Management

Medical Education

Data Generation

Stakeholder Collaboration

Conference Presentation

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free